The efficiency of nerve guide conduits (NGCs) in repairing
peripheral
nerve injury is not high enough yet to be a substitute for autografts
and is still insufficient for clinical use. To improve this efficiency,
3D electrospun scaffolds (3D/E) of poly(l-lactide-co-ε-caprolactone) (PLCL) and poly(l-lactide-co-glycolide) (PLGA) were designed and fabricated by the
combination of 3D printing and electrospinning techniques, resulting
in an ideal porous architecture for NGCs. Polypyrrole (PPy) was deposited
on PLCL and PLGA scaffolds to enhance biocompatibility for nerve recovery.
The designed pore architecture of these “PLCL-3D/E”
and “PLGA-3D/E” scaffolds exhibited a combination of
nano- and microscale structures. The mean pore size of PLCL-3D/E and
PLGA-3D/E scaffolds were 289 ± 79 and 287 ± 95 nm, respectively,
which meets the required pore size for NGCs. Furthermore, the addition
of PPy on the surfaces of both PLCL-3D/E (PLCL-3D/E/PPy) and PLGA-3D/E
(PLGA-3D/E/PPy) led to an increase in their hydrophilicity, conductivity,
and noncytotoxicity compared to noncoated PPy scaffolds. Both PLCL-3D/E/PPy
and PLGA-3D/E/PPy showed conductivity maintained at 12.40 ± 0.12
and 10.50 ± 0.08 Scm–1 for up to 15 and 9 weeks,
respectively, which are adequate for the electroconduction of neuron
cells. Notably, the PLGA-3D/E/PPy scaffold showed superior cytocompatibility
when compared with PLCL-3D/E/PPy, as evident via the viability assay,
proliferation, and attachment of L929 and SC cells. Furthermore, analysis
of cell health through membrane leakage and apoptotic indices showed
that the 3D/E/PPy scaffolds displayed significant decreases in membrane
leakage and reductions in necrotic tissue. Our finding suggests that
these 3D/E/PPy scaffolds have a favorable design architecture and
biocompatibility with potential for use in peripheral nerve regeneration
applications.